WELLINGTON MANAGEMENT GROUP LLP

Position in MDXG — Mimedx Group, Inc.

CIK 902219 Boston, MA

Position in MDXG

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$1,347,426

+$19,840 QoQ

Shares Held

349,981

+4.1% QoQ

Ownership

0.240%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#39

of 226 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 0% Shared 70% None 30%

Healthcare · as of Jun 30, 2026

WELLINGTON MANAGEMENT GROUP LLP holds $15,052,705,482 across 207 Biotechnology names. MDXG ranks #142 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	3,247,658	$1,613,209,155
2	ARGX	Argenx SE	930,548	$863,334,513
3	REGN	Regeneron Pharmaceuticals, Inc.	1,270,087	$791,950,042
4	RVMD	Revolution Medicines, Inc.	3,843,415	$719,794,757
5	ALNY	Alnylam Pharmaceuticals, Inc.	2,110,407	$635,295,816
6	IONS	Ionis Pharmaceuticals Inc	7,651,415	$606,680,693
7	CYTK	Cytokinetics Inc	6,931,770	$590,517,483
8	MDGL	Madrigal Pharmaceuticals, Inc.	825,714	$443,367,129

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,347,426	349,981	+4.1%	Shares	Defined	2026-08-14
2026-03-31	$1,327,586	336,098	-8.4%	Shares	Defined	2026-05-15
2025-12-31	$2,483,127	366,784	-9.3%	Shares	Defined	2026-02-17
2025-09-30	$2,821,922	404,287	+14.9%	Shares	Defined	2025-11-14
2025-06-30	$2,149,057	351,728	-6.6%	Shares	Defined	2025-08-14
2025-03-31	$2,860,692	376,407	-3.4%	Shares	Defined	2025-05-13
2024-12-31	$3,748,969	389,706	+22.8%	Shares	Defined	2025-02-12
2024-09-30	$1,875,088	317,274	+11.8%	Shares	Defined	2024-11-14
2024-06-30	$1,966,823	283,813	+6.2%	Shares	Defined	2024-08-14
2024-03-31	$2,057,378	267,192	+134.6%	Shares	Defined	2024-05-15
2023-12-31	$998,815	113,890	—	Shares	Defined	2024-02-12
No filing history on record for this holder in this stock.